PQ 625
625. Deputy Catherine Callaghan asked the Minister for Health if she will provide an update on the progress of the Full Health Technology Assessment (HTA) for a drug (details supplied) for the treatment of eosinophilic oesophagitis, which was commissioned by the HSE on 25 June 2024, when the assessment is expected to be completed and whether consideration is being given to making this drug available under the Medical Card Scheme, Drugs Payment Scheme or other community drug reimbursement arrangements, given its importance for patients living with this chronic condition. [67023/26]
Introduced
22 September 2026
Last action
22 September 2026 · Medicinal Products
Status
written
Sponsors
Catherine Callaghan
Subjects
Discovery layer
Source updated
22 September 2026
Summary
625. Deputy Catherine Callaghan asked the Minister for Health if she will provide an update on the progress of the Full Health Technology Assessment (HTA) for a drug (details supplied) for the treatment of eosinophilic oesophagitis, which was commissioned by the HSE on 25 June 2024, when the assessment is expected to be completed and whether consideration is being given to making this drug available under the Medical Card Scheme, Drugs Payment Scheme or other community drug reimbursement arrangements, given its importance for patients living with this chronic condition. [67023/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
22 September 2026
Medicinal Products
625. Deputy Catherine Callaghan asked the Minister for Health if she will provide an update on the progress of the Full Health Technology Assessment (HTA) for a drug (details supplied) for the treatment of eosinophilic oesophagitis, which was commissioned by the HSE on 25 June 2024, when the assessment is expected to be completed and whether consideration is being given to making this drug available under the Medical Card Scheme, Drugs Payment Scheme or other community drug reimbursement arrangements, given its importance for patients living with this chronic condition. [67023/26]
Source: written
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Medicinal Products
xml · EN · 22 September 2026
Sponsors
- Catherine Callaghan · Asking member
- Health · Health · Addressed to
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-09-22/625/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-09-22/pq_625
- ireland · q-2026-09-22-pq_625 · source updated 22 September 2026